US Patent 11124538 Neuroactive steroids, compositions, and uses thereof

Patent 11124538 was granted and assigned to SAGE Therapeutics on September, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11124538

Date of Patent

September 21, 2021

Patent Application Number

20190430

Date Filed

April 30, 2019

Patent Citations Received

‌

US Patent 12083131 Neuroactive steroids, compositions, and uses thereof

‌

US Patent 12060386 Compositions and methods for treating CNS disorders

‌

US Patent 11945836 Compositions and methods for treating CNS disorders

Patent abstract

Described herein are neuroactive steroids of the Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11124538 Neuroactive steroids, compositions, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API